Lv11
30 积分 2025-06-21 加入
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies
13分钟前
待确认
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies
2小时前
已完结
Tofacitinib for Acute Severe Ulcerative Colitis: A Systematic Review
5小时前
已完结
New Therapeutics for Ulcerative Colitis
6天前
已完结
Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments
7天前
已完结
皖公网安备34019202002308
